LAB
STANDARD BIOTOOLS INC. · Healthcare · Market cap $278.4M
Insider Buying
$14.4M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Aug 24, 2026
Casdin Partners Master Fund, L.P.
STANDARD BIOTOOLS INC. (LAB) has 32 SEC Form 4 filings (46 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 24, 2026.
Inside the rolling window, 1 insider at STANDARD BIOTOOLS INC. reported 15 open-market purchases totaling $14.4M and no open-market sales. The most active filer is Director, 10% Owner Casdin Partners Master Fund, L.P. with 15 filings. The most recent open-market filing is a purchase of 125,000 shares by Director, 10% Owner Casdin Partners Master Fund, L.P., dated Dec 2, 2025, worth $178K.
- Industry:Medical - Specialties
- CEO:Michael Egholm
- Employees:387
- HQ:Boston, MA, US
- IPO:2011-02-10
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director, 10% Owner | Purchase | 125,000 | $178K | Dec 4 | -50.8% | SEC ↗ | |
| Director, 10% Owner | Purchase | 75,000 | $108K | Dec 4 | -50.8% | SEC ↗ | |
| Director, 10% Owner | Purchase | 150,000 | $217K | Dec 4 | -50.8% | SEC ↗ | |
| Director, 10% Owner | Purchase | 150,000 | $215K | Nov 26 | -50.4% | SEC ↗ | |
| Director, 10% Owner | Purchase | 7,550,000 | $9.8M | Nov 26 | -50.4% | SEC ↗ | |
| Director, 10% Owner | Purchase | 275,000 | $339K | Nov 20 | -44.6% | SEC ↗ | |
| Director, 10% Owner | Purchase | 350,000 | $449K | Nov 20 | -44.6% | SEC ↗ | |
| Director, 10% Owner | Purchase | 450,000 | $586K | Nov 20 | -44.6% | SEC ↗ | |
| Director, 10% Owner | Purchase | 450,000 | $541K | Nov 17 | -41.4% | SEC ↗ | |
| Director, 10% Owner | Purchase | 250,000 | $310K | Nov 17 | -41.4% | SEC ↗ | |
| Director, 10% Owner | Purchase | 225,000 | $276K | Nov 17 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 225,000 | $253K | Nov 12 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 275,000 | $322K | Nov 12 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 300,000 | $359K | Nov 12 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 375,000 | $446K | Nov 12 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does LAB have?
STANDARD BIOTOOLS INC. (LAB) has 32 SEC Form 4 filings (46 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 24, 2026.
When was the most recent SEC Form 4 filing for LAB?
The most recent Form 4 filing for LAB on Tracefour is dated Aug 24, 2026.
Who is the most active insider at LAB?
The most active SEC Form 4 filer at LAB in the rolling window is Director, 10% Owner Casdin Partners Master Fund, L.P., with 15 filings.
What is the total insider buy and sell value at LAB in the current window?
Inside the rolling window, insiders at LAB bought $14.4M and sold $0 based on SEC Form 4 filings.
Can I get alerts for LAB insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at STANDARD BIOTOOLS INC. (LAB). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
STANDARD BIOTOOLS INC. is in the Healthcare sector.